MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0029191
Shreepati Pharmaceuticals Pvt Ltd - pharma in Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.91 Cr
▲ 7% YoY
Net profit · FY 2025
₹1.56 Cr
Net margin 5.6%
EBITDA · FY 2025
₹4.35 Cr
EBITDA margin 15.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4.61 Lakh
Issued & subscribed
Open charges
₹2.75 Cr
Secured borrowings
Company age
31 yrs
Est. 1995
Employees · EPFO
53
Provident fund records
About Shreepati Pharmaceuticals Pvt Ltd
Data last updated:
Shreepati Pharmaceuticals Pvt Ltd is a private limited company based in Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1995PTC009950. Its GSTIN is 23AACCS4103P1ZF (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.61 Lakh. It is led by directors including Rajesh Muchhal and Vedant Muchhal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 – Silver Arc Plaza 20/1 New Palasia Indore, Madhya Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.91 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.56 Cr (net margin 5.6%) and EBITDA of ₹4.35 Cr (EBITDA margin 15.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 3% over five years.
The company has about 53 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shreepati Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.75 Cr on record.
Shreepati Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0029191). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreepati.com.
Company details
CIN U24232MP1995PTC009950
Registration Number 009950
Incorporation Date 08 September 1995
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0029191
Recognitions & Rankings of Shreepati Pharmaceuticals
Contact details
Shreepati Pharmaceuticals Pvt Ltd's registered office is in Madhya Pradesh. Its website is shreepati.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address208 – Silver Arc Plaza 20/1 New Palasia Indore, Madhya Pradesh, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Shreepati Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Shreepati Pharmaceuticals operates one associated brand: Shreepati Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports raw materials for the pharmaceutical industry. | shreepati.com |
Business activity
The main business activity of Shreepati Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Shreepati Pharmaceuticals Pvt Ltd
FY 2025 filings availableShreepati Pharmaceuticals Pvt Ltd reported revenue of ₹27.91 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹27.91 Cr ▲ 7%
Net profit · FY 2025
₹1.56 Cr margin 5.6%
EBITDA · FY 2025
₹4.35 Cr margin 15.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 9%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 3%
5 years · compounded
▼ 3%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 7% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.35 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.56 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.6% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Shreepati Pharmaceuticals Pvt Ltd
Shreepati Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Muchhal Also directs: Shreepati Molecules Private Limited | Director | 16 Jun 1999 | 27 Years 4 Months | Current |
| Vedant Muchhal | Director | 28 Mar 2016 | 10 Years 7 Months | Current |
| Dhiraj Muchhal | Director | 28 Mar 2016 | 10 Years 7 Months | Current |
| Ravi Muchhal Also directs: Shreepati Molecules Private Limited | Director | 16 Jun 1999 | 27 Years 4 Months | Current |
Peer comparison
Shreepati Pharmaceuticals Pvt Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indus Pharma Private Limited | ₹28.11 Cr (FY 2023) | -58.0% | New Delhi, Delhi, India | |||
| Inven Pharmaceuticals Private Limited | ₹27.99 Cr (FY 2025) | -6.0% | Indore, Madhya Pradesh, India | |||
| Aashka Formulation Private Limited | ₹27.95 Cr (FY 2022) | 904.0% | Kalol, Gujarat, India | |||
| Danashmand Organic Private Limited | ₹27.92 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Shreepati Pharmaceuticals Pvt Ltdthis company | ₹27.91 Cr (FY 2025) | ₹1.56 Cr | 5.6% | 7.0% | 53 | Madhya Pradesh, India |
| Sellwell Pharmaceuticals Limited | ₹27.85 Cr (FY 2024) | -21.0% | Madhya Pradesh, India | |||
| Memphis Vision Care Private Limited | ₹27.83 Cr (FY 2024) | 106.0% | Chhatral, Gujarat, India | |||
| Synac Pharmaceuticals Private Limited | ₹27.79 Cr (FY 2025) | 311.0% | Hyderabad, Telangana, India | |||
| Anthea Pharma Private Limited | ₹27.78 Cr (FY 2025) | 516.0% | Hyderabad, Telangana, India | |||
| Lifesticks Pharmaceuticals Private Limited | ₹27.68 Cr (FY 2025) | 196.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Shreepati Pharmaceuticals Pvt Ltd is audited by AVINASH AGRAWAL & COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVINASH AGRAWAL & COMPANY | FY 2022 | 022666C |
Shareholding
The shareholding of Shreepati Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹2.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2017 | 100079941 | Others | ₹2.75 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Shreepati Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shreepati Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shreepati Pharmaceuticals Pvt Ltd has a workforce of 53 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
53
Active EPFO establishments
1
Employee growth
1.92%
GST
Shreepati Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCS4103P1ZF | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shreepati Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Shreepati Pharmaceuticals Pvt Ltd has 6 board changes on record since 1999: 4 appointments and 2 cessations. The latest: Taramani Muchhal ceased to be Director on 19 Jun 2017.
AGM
Shreepati Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shreepati Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Ceased
Taramani Muchhal ceased to be Director.
Charges
A charge with Others amounted to Rs. 275.00 Lakh with Charge ID 100079941 was registered on 30 Jan 2017.
Appointed
Dhiraj Muchhal was appointed as Director.
Appointed
Vedant Muchhal was appointed as Director.
Ceased
Gokuldas Muchhal ceased to be Director.
Appointed
Rajesh Muchhal was appointed as Director.
Appointed
Ravi Muchhal was appointed as Director.
Incorporation
08 Sep 1995
Shreepati Pharmaceuticals Pvt Ltd was registered on 08 Sep 1995 with Roc Gwalior & aged 31 years 1 month as per MCA records.
Frequently asked questions
Shreepati Pharmaceuticals is an active private limited company based in Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 1995 (31+ years old) and is registered under CIN U24232MP1995PTC009950.
Shreepati Pharmaceuticals has 4 current directors:
- Rajesh Muchhal - Director
- Vedant Muchhal - Director
- Dhiraj Muchhal - Director
- Ravi Muchhal - Director
The latest financial statements of Shreepati Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shreepati Pharmaceuticals is 23AACCS4103P1ZF, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Shreepati Pharmaceuticals is U24232MP1995PTC009950. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreepati Pharmaceuticals was incorporated on 08 September 1995, making it 31+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Shreepati Pharmaceuticals by revenue are Indus Pharma Private Limited, Inven Pharmaceuticals Private Limited, Aashka Formulation Private Limited, Danashmand Organic Private Limited, Sellwell Pharmaceuticals Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Taramani Muchhal ceased to be Director on 19 Jun 2017. Dhiraj Muchhal was appointed as Director on 28 Mar 2016. Vedant Muchhal was appointed as Director on 28 Mar 2016. Shreepati Pharmaceuticals has 6 board changes on record in total.
Yes, Shreepati Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0029191).
Shreepati Pharmaceuticals can be reached through the website shreepati.com. Its registered office is in Madhya Pradesh, India.
The registered office of Shreepati Pharmaceuticals is at 208 – Silver Arc Plaza 201 New Palasia Indore, Madhya Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages